FOR PATIENTS (QUICK LINKS)

At Genomic Medicine UK, we provide a comprehensive panel of genomic tests and services. Our highly qualified consultant medical doctors carry out our extensive tests and services using state-of-the-art advanced technologies such as next-generation DNA sequencing and DNA chip microarray technology. You can find below a list of the genomic tests and services that we provide at Genomic Medicine UK:

  1. 1
    PERSONALISED MEDICAL TREATMENTS FOR DISEASES

    Innovative DNA testing to explore how your genes can affect and modulate your response to prescribed drugs. The response and speed of metabolism of any given prescribed medication are not at the same level between any two individuals. This type of testing is vital to help your family doctor or your treating specialist to prescribe effective, safe medications and adjust your medicament doses in a personalised approach that will be tailored according to your genetic makeup. We can provide individualised medical treatment assessment for all the common diseases listed hereunder (please read this important note):

    CARDIOVASCULAR DISORDERS

     

    CHILDREN’S HEALTH

     

    DERMATOLOGY AND SKIN DISORDERS

     

    ENDOCRINE AND METABOLIC DISORDERS

     

    GASTROINTESTINAL DISORDERS

     

    HAEMATOLOGIC DISORDERS

     

    HEAD AND NECK DISORDERS

     

    INFECTIOUS DISEASES

     

    MEN’S HEALTH

     

    NERVOUS SYSTEM DISORDERS

     

    PSYCHIATRIC DISORDERS

     

    RESPIRATORY SYSTEM DISORDERS

     

    RHEUMATOLOGY AND THE MUSCULOSKELETAL SYSTEM DISORDERS

     

    SEXUALLY TRANSMITTED DISEASES

     

    UROGENITAL TRACT DISORDERS

     

    WOMEN’S HEALTH

  2. 2
    GENOMIC RISK ASSESSMENT FOR HEREDITARY MALIGNANCIES (CANCERS)

    Modern DNA analysis using the cutting edge technology of next-generation DNA sequencing to find out whether your genetic background may increase your risk of developing a specific type of malignant tumours (cancers). These types of genomic testing are recommended if you have a strong family history of malignant tumours (i.e. first-degree relative who has been diagnosed with the cancer type you are concerned about). By knowing your genetic background and your hereditary risk for developing certain types of malignancies, you can make informed decisions regarding your lifestyle, which may dramatically reduce your risk of developing a malignant tumour. If your results show that you are genetically predisposed to developing a specific type of malignancy, your prognosis will be significantly improved by having regular health screenings at shorter intervals. We can conduct genomic risk assessments for different types of malignant tumours, which may arise in the following organs:

  3. 3
    THE LIQUID BIOPSY CLINIC FOR EARLY DETECTION OF CANCER
  4. 4
    CTC LIQUID BIOPSY FOR CANCERS TREATMENT SUCCESS AND COMPLETE REMISSION ASSESSMENT (CIRCULATING TUMOUR CELLS BLOOD TEST)

    Cancer treatment and remission circulating tumour cell monitor is a non-invasive, highly accurate, and affordable blood test specifically designed for better management of cancer patients.

    This advanced genomic test is designed for seventeen different cancer types of epithelial origin and can be utilised as an ancillary tool for recurrence and response to treatment monitoring without subjecting the patient to invasive procedures and harmful radiation.

    Cancer treatment and remission CTC monitor test is conventionally named as a “liquid biopsy” and can be used at any time during a patient’s course of the disease:

  5. 5
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR ALZHEIMER’S AND AMD DISEASES
  6. 6
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR CARDIOVASCULAR DISEASES
  7. 7
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR METABOLIC DISEASES
  8. 8
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR OSTEOARTICULAR DISEASES
  9. 9
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR ALZHEIMER’S DISEASE
  10. 10
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR AGE-RELATED MACULAR DEGENERATION
  11. 11
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR ARTERIAL THROMBOSIS
  12. 12
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR ATHEROSCLEROSIS
  13. 13
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR CORONARY ARTERY DISEASE
  14. 14
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR GESTATIONAL THROMBOSIS
  15. 15
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR HORMONE REPLACEMENT THERAPY (HRT) INDUCED THROMBOSIS
  16. 16
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR ISCHAEMIC HEART ATTACK
  17. 17
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR ISCHAEMIC STROKE
  18. 18
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR LONG QT SYNDROME AND SUDDEN CARDIAC ARREST
  19. 19
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR A LUNG EMBOLISM
  20. 20
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR VENOUS THROMBOSIS
  21. 21
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR DIABETES TYPE II
  22. 22
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR HIGH HOMOCYSTEINE
  23. 23
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR HYPERCHOLESTEROLAEMIA
  24. 24
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR HYPERLIPIDAEMIA
  25. 25
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR HYPERTENSION
  26. 26
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR METABOLIC SYNDROME
  27. 27
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR SYMPTOMATIC AND SILENT GLUTEN INTOLERANCE
  28. 28
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR SYMPTOMATIC AND SILENT LACTOSE INTOLERANCE
  29. 29
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR CHRONIC BACK PAIN
  30. 30
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR DEGENERATIVE DISC DISEASE
  31. 31
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR DEGENERATIVE JOINT DISEASE
  32. 32
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR OSTEOARTHRITIS
  33. 33
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR OSTEOPENIA
  34. 34
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR OSTEOPOROSIS
  35. 35
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTIVE MEDICINE FOR RHEUMATOID ARTHRITIS
  36. 36
    GENOMIC RISK ASSESSMENT AND PERSONALISED ANTI-AGEING PREVENTIVE MEDICINE

    Ageing is a natural process, but our genetic background holds unique data about how we age. Genomic testing allows us to unlock this data and use it to identify how a person can optimise their health, and ultimately prolong their life according to their unique genetic background, and delay as much as possible the effects of ageing on the body.

  37. 37
    GENOMIC RISK ASSESSMENT AND PERSONALISED PREVENTATIVE MEDICINE FOR SPORTS PERFORMANCE

    Sports people require optimal health and fitness in order to perform to the best of their physical capabilities. However, some people are genetically predisposed to develop conditions which may, in the future, inhibit their ability to participate in sporting and other physical activities.

  38. 38
    NUTRITIONAL MEDICINE GENOMIC TESTS

    Cutting edge DNA testing to find out the effects of certain foods and micronutrients on your gene expression as well as the impact of your unique genetic background on your metabolism of macronutrients and micronutrients and how these effects consequently impact your general health and ability to cope with chronic diseases. The results of your DNA genetic testing will provide you with information as to how your lifestyle and environment can affect and modulate your genetic background and gene functionality and how your genetic profile might affect your metabolism of food and nutrients. In other words, it will help you to know how your life choices can influence and interact with your genes. Please remember that your genes do not mean that an inevitable outcome is your destiny. The truth is that you can change the way your genes express themselves by making different lifestyle choices, such as your choice of the food and micronutrients you consume.

    The following nutritional medicine genomic DNA tests will enhance your powers to adopt a healthier lifestyle by optimising your dietary choices to be consistent with your genetic profile. Moreover, these tests will be invaluable in providing you with helpful tools to enhance the efficiency of your weight control efforts to maintain an ideal weight without compromising your lifestyle quality:

  39. 39
    GENOMIC RISK ASSESSMENT & PERSONALISED MEDICAL TREATMENTS FOR COMMON DISEASES

    Advanced DNA analysis to find out whether your genetic background may increase your risk of developing certain types of diseases. This genomic test is recommended if you have a strong family history of any the diseases listed below (i.e. first-degree relative who has been diagnosed with any of these diseases) or you have one or more risk factor for this disease. By knowing your genetic background and your risk for developing certain types of illnesses, you can make informed decisions regarding your lifestyle, which may dramatically reduce your risk of developing these diseases. For example, you may be predisposed to develop diabetes type II, hypertension or cardiovascular diseases, all of which can be delayed or entirely avoided if you follow certain healthy life choices at an earlier stage in your life. We can conduct a genomic risk assessment for the following common diseases:

  40. 40
    PRECISION MEDICINE CLINIC
  41. 41
    WELL PERSON HEALTH ASSESSMENT AND MEDICAL MOT

    Well person health assessments and medical MOTs are a group of systematic health assessments that adopt a core set of state-of-the-art genomic tests and medical assessments in a methodological approach to give you a comprehensive overview of your holistic health.

    After your personalised health assessment and medical MOT, you will receive a comprehensive individualised medical report that includes all your test results, easy to understand the interpretation of your test results and thorough recommendations prepared by one of our consultant medical doctors to help you to achieve your goals from the health assessment and medical MOT programme you have chosen according to your age group from the list below:

  42. 42
    SPECIALISED HEALTH CHECK-UPS

    Specialised health checkups are a group of systematic health assessments that adopt a core set of state-of-the-art genomic tests and medical assessments in a methodological approach to give you a comprehensive overview of your body systems health.

    These cutting-edge personalised health assessments include a comprehensive DNA assessment for your hereditary genetic mutations and traits, which are responsible for increasing the risk of developing cancer. You will also be tested selectively for the most relevant tumour markers, according to your medical history, symptoms and personal concerns.

  43. 43
    ADVANCED BIOMARKERS TESTS BY POST

    METABOLIC HEALTH BIOMARKERS BY POST

     

    HORMONAL HEALTH BIOMARKERS BY POST

     

    IMMUNITY HEALTH BIOMARKERS BY POST

     

    SEXUAL HEALTH BIOMARKERS BY POST

     

    CANCER BIOMARKERS BY POST

     

    GENERAL HEALTH AND WELLBEING BIOMARKERS BY POST

  44. 44
    ADVANCED BIOMARKERS TESTS IN THE LABORATORY OR BY HOME VISITS

    WELL PERSON HEALTH ASSESSMENTS

     

    CANCER BIOMARKERS

  45. 45
    GENOMIC CANCER PREVENTION TESTS

    Genomic cancer prevention tests are a group of innovative genomic DNA tests designed to investigate if you are at a higher risk of developing specific type cancer than the average population due to a higher number of hereditary SNPs (single nucleotide polymorphisms), which are minor alterations in your DNA genetic code that you inherited from your parents and made you who you are.

    At present, we know of hundreds of SNPs that increase the risk for developing certain types of cancers and the more you have of these SNPs in your DNA genetic code, the higher is your lifetime risk for developing the disease linked to the SNPs you have in your DNA.

    The objective of the following genomic cancer prevention tests is to assess how many of these SNPs you have in your genetic code in order to determine your lifetime risk for developing a specific type of cancer and categorise your risk as low, moderate or high risk from genomic medicine perspective:

  46. 46
    SCREENING FOR CANCER BY POST OR IN THE CLINIC

    Cancer screening is a systematic health assessment for people without current signs or symptoms of cancer, which is designed medically to detect cancer at its early stages when it is most likely to be treatable.

  47. 47
    TARGETED CANCER THERAPY AND ONCOLOGY PHARMACOGENOMICS

    Malignant tumours classification is conventionally based on the tissue differentiation level and the organ of origin. However, the recent advancement in genomic medicine has shifted the paradigm towards a molecular classification of malignancies so that each tumour can be categorised according to the genomic somatic alterations in the genes driving tumorigenesis in the DNA of the tumours cells per se. These specific genomic alterations in any given tumour provide invaluable insights into drug sensitivity and/or resistance as well as disease prognosis, thus enabling personalised care of each cancer patient after being diagnosed with a malignancy.

    Moreover, precision oncology pharmacogenomics is the study of the effect of inherited genomic variations on cancer chemotherapy response. In cancer treatment, there are at least two genomes of importance: the patient’s germline genome (inherited genome variation) and the tumour genome (inherited genome variation plus acquired genome variation). The latter can be studied extensively through high throughput DNA sequencing and to a lesser extent by immunohistochemistry, to find out the driver mutations and the other genomic alterations, which are responsible for the tumorigenesis process and cancer growth. Nonetheless, a comprehensive precision oncology approach needs to interrogate multiple mechanisms of genome variation in both germline and tumour genetic material to assess their influence on the available chemotherapy drugs/protocols for the clinical case of a cancer patient.

    The oncologic pharmacogenomic analysis of the patient’s germline genome (inherited genome variation) would augments the knowledge obtained by next-generation sequencing of the tumour DNA, according to which the targeted cancer therapy can be decided, by assessing the speed of metabolising any chemotherapy drug candidate by the cytochrome enzymatic system in the patient’s body, which could be either normal, slow, fast or no metabolism of this drug. It also assesses the inherited genomic risk for developing side effects if being treated with this chosen chemotherapy drug.

    At genomic medicine UK we offer the following comprehensive targeted cancer therapy and oncology pharmacogenomics tests:

    TARGETED CANCER THERAPY AND ONCOLOGY PHARMACOGENOMICS

  48. 48
    PRECISION ONCOLOGY PHARMACOGENOMICS

    Precision oncology pharmacogenomics is the study of the effect of inherited genomic variations on cancer chemotherapy response. In cancer treatment, there are at least two genomes of importance: the patient’s germline genome (inherited genome variation) and the tumour genome (inherited genome variation plus acquired genome variation). The latter can be studied extensively through high throughput DNA sequencing and to a lesser extent by immunohistochemistry, to find out the driver mutations and the other genomic alterations, which are responsible for the tumorigenesis process and cancer growth. Nonetheless, a comprehensive precision oncology approach need to interrogate multiple mechanisms of genome variation in both germline and tumour genetic material to assess their influence on the available chemotherapy drugs/protocols for the clinical case of a cancer patient.

    Precision oncology pharmacogenomic analysis of the patient’s germline genome (inherited genome variation) examines the speed of metabolising any chemotherapy drug candidate by the cytochrome enzymatic system in the patient’s body, which could be either normal, slow, fast or no metabolism of this drug. It also assesses the inherited genomic risk for developing side effects if being treated with this chosen chemotherapy drug.

    At genomic medicine UK we offer the following precision oncology pharmacogenomics tests:

  49. 49
    PRECISION SEXUAL MEDICINE

    Sex is a vital part of the emotional and physical health. In a relationship, sexual activity allows individuals to establish intimacy and express their feelings to their partner. It also benefits the overall physical health of each partner in a relationship by reducing stress and making the partners feel good about themselves.

    Sexually transmitted infections (STIs) are a group of infections the individual can catch by practising sex with someone who has a sexually transmitted infection. These infections are usually passed from person to person through unprotected vaginal intercourse with a condom, but they can also be passed through unprotected anal sex, oral sex or skin-to-skin contact. STIs can be caused by viruses or bacteria. STIs caused by viruses include hepatitis B, herpes, HIV and the human papillomavirus (HPV). STIs caused by bacteria include chlamydia, gonorrhoea and syphilis.

    At Genomic Medicine UK, we offer the following personalised molecular tests that cover almost all the major sexually transmitted infections stated above.

    PERSONALISED SEXUAL HEALTH CHECK-UP

  50. 50
    PREVENTIVE AND DIAGNOSTIC MEDICAL TESTS

    We have created a unique group of preventive and diagnostic blood testing profiles that offer excellent insight and overview of your overall health and well-being.

  51. 51
    PERSONALISED MOLECULAR PATHOLOGY AND CLINICAL INVESTIGATIONS
  52. 52
    PERSONALISED MEDICAL TREATMENTS WITH INDIVIDUAL MEDICINES

    Innovative DNA testing to explore how your genes can affect and modulate your response to a prescribed drug. The response and speed of metabolism of any given prescribed medication are not at the same level between any two individuals. This type of testing is vital to help your family doctor or your treating specialist to prescribe effective, safe medications and adjust your medicament doses in a personalised approach that will be tailored according to your genetic makeup. We can provide personalised medical treatment assessment for the 2329 medicines listed below, which comprise the majority of the prescribed medicaments by the family doctors and specialists in the United Kingdom and worldwide (please read this important note):

  53. 53
    PERSONALISED CANCER SCREENING CONSULTATION
  54. 54
    GENOMIC MEDICINE CONSULTATION
  55. 55
    ONLINE CANCER RISK ASSESSMENT

    The online cancer risk assessment is a thorough assessment by consultant medical doctors to your:

    • Family pedigree analysis
    • Hereditary genetic syndromes analysis
    • Risk assessment for hereditary cancers
    • Medical history review
    • Surgical history review
    • Allergic reactions assessment
    • Lifestyle assessment
    • Dietary assessment
    • Physical activity assessment
    • Family medical history
    • Immunisation history
    • Medical tests history
    • Endocrine symptoms review
    • Dermatologic symptoms review
    • Respiratory symptoms review
    • Cardiovascular symptoms review
    • Gastrointestinal symptoms review
    • Urinary symptoms review
    • Musculoskeletal symptoms review
    • Genital tract symptoms review
    • Gender-specific symptoms review
    • Prescription medications intake review
    • Over the counter/non-prescription medications review
    • Supplements and vitamins intake review

    In order to provide you with a personalised medical report that assesses your hereditary, clinical and environmental risks for developing:

    • Anal cancer
    • Bladder cancer
    • Bone tumours
    • Brain cancer
    • Breast cancer
    • Bowel cancer
    • Cervical cancer
    • Kidney cancer
    • Liver cancer
    • Lung cancer
    • Lymphoma and leukaemia
    • Male breast cancer
    • Mouth cancer
    • Oesophagus cancer
    • Ovarian cancer
    • Pancreas cancer
    • Penile cancer
    • Prostate cancer
    • Skin cancer
    • Stomach cancer
    • Testicular cancer
    • Throat cancer
    • Thyroid cancer
    • Uterine cancer
    • Vaginal cancer
    • Vulval cancer

    ONLINE CANCER RISK ASSESSMENT FOR WOMEN
    ONLINE CANCER RISK ASSESSMENT FOR MEN

X